CheckMyRecalls

Mckesson Medical-Surgical Inc. Corporate Office recalls Infuvite Adult…

Mckesson Medical-Surgical Inc. Corporate Office recalls Infuvite Adult and 1 more

Published
7 May 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton, NJ 08540, Distributed by Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product of Canada, NDC 54643-5649-1

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01

Brand / company
Mckesson Medical-Surgical Inc. Corporate Office
Codes / lots
Lot #: AA2279, Exp 8/31/26; AA2383, Exp 9/30/26 | Lot #: 1MP24042, Exp 6/30/26
Distribution
Distributed to Medical Facilities in MS and FL.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.